$1.96 billion in FY2025. $438 million in state taxes. The highest prices in America — and the first-ever annual decline.
Illinois deliberately built a supply-constrained, high-tax market with the most ambitious social equity program in cannabis. For four years, that bet paid off in consecutive records. FY2025 ended it: $1.963B in sales, down 2.2% from the FY2024 peak. The state issued 93 new dispensary licenses — the most ever — while revenue fell. The protected market is now experiencing the same math every other state faces.
2013 — Compassionate Use Act (Medical)
Illinois legalizes medical cannabis with one of the most restrictive programs in the country. 21 cultivation centers and 55 dispensaries licensed. Patient qualifying conditions are narrow. The limited-license model becomes the foundation for everything that follows.
2019 — Cannabis Regulation and Tax Act
Governor Pritzker signs the most comprehensive cannabis legalization in U.S. history. First state to legalize through legislature rather than ballot. Tiered excise taxes (10%/20%/25% by THC), social equity licensing, automatic expungement, and the R3 grant program for impacted communities. The tax structure is designed to generate maximum revenue.
2020 — Launch and Lines
Adult-use sales begin January 1, 2020. Day-one lines stretch for blocks. First year: $669M in adult-use despite pandemic shutdowns. Supply constraints keep prices elevated. Out-of-state customers from Indiana, Iowa, and Wisconsin drive 20%+ of revenue. Illinois becomes the #3 market nationally almost immediately.
2021–2022 — The Billion-Dollar Build
Sales climb past $1.5B, then $1.8B. Social equity lottery awards conditional licenses, but litigation delays openings. Monthly revenue stabilizes at $120–140M. Illinois flower prices are 2.5–3x neighboring Michigan — the supply constraint and tax burden creating the largest price gap between adjacent states in cannabis.
2023 — Social Equity Dispensaries Open
New dispensaries finally open after years of delays. Total reaches 200+. Sales hit $1.59B in adult-use. The market absorbs new competition while still setting records. But per-unit prices start declining as competition increases. Illinois passes $244M in cumulative R3 grants to impacted communities.
2024 — The Revealing Math
Fourth consecutive record: $2.007B in sales, $424.7M in state tax revenue. But the numbers tell a different story beneath the surface. Items sold surged 13% to 56.3 million. Revenue grew only 2.5%. That gap — 13% more product for 2.5% more money — is price compression arriving at America’s most expensive market. 244 dispensaries now open, with 120+ conditional licenses still pending.
FY2025 — The First Decline
For the first time ever, annual sales fall: $1.963B — down 2.2% from the FY2024 peak. The state issues 93 new dispensary licenses — the most of any year — as social equity licenses finally reach operational status. More dispensaries, lower revenue: the supply wave Illinois delayed for years is arriving. State tax collections hit $438.2M — up slightly, because the tax structure captures revenue even as prices compress. Cumulative sales since 2020: $9.23B.